
Global Typhoid Vaccine Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Typhoid Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Typhoid Vaccine market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Typhoid Vaccine market include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Typhoid Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Typhoid Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Typhoid Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Typhoid Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Typhoid Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Typhoid Vaccine sales, projected growth trends, production technology, application and end-user industry.
Typhoid Vaccine Segment by Company
Actiza Pharmaceutical
Bharat Biotec
Merit Pharmaceuticals
PaxVax
GlaxoSmithKline
Merck
Sanofi
Typhoid Vaccine Segment by Type
Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine
Typhoid Vaccine Segment by Application
Pharmaceutical & Biotechnology Companies
Hospital
Research & Academic Laboratories
Others
Typhoid Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Typhoid Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Typhoid Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Typhoid Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Typhoid Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Typhoid Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Typhoid Vaccine industry.
Chapter 3: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Typhoid Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Typhoid Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Typhoid Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Typhoid Vaccine market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Typhoid Vaccine market include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Typhoid Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Typhoid Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Typhoid Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Typhoid Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Typhoid Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Typhoid Vaccine sales, projected growth trends, production technology, application and end-user industry.
Typhoid Vaccine Segment by Company
Actiza Pharmaceutical
Bharat Biotec
Merit Pharmaceuticals
PaxVax
GlaxoSmithKline
Merck
Sanofi
Typhoid Vaccine Segment by Type
Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine
Typhoid Vaccine Segment by Application
Pharmaceutical & Biotechnology Companies
Hospital
Research & Academic Laboratories
Others
Typhoid Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Typhoid Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Typhoid Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Typhoid Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Typhoid Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Typhoid Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Typhoid Vaccine industry.
Chapter 3: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Typhoid Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Typhoid Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
193 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Typhoid Vaccine Sales Value (2020-2031)
- 1.2.2 Global Typhoid Vaccine Sales Volume (2020-2031)
- 1.2.3 Global Typhoid Vaccine Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Typhoid Vaccine Market Dynamics
- 2.1 Typhoid Vaccine Industry Trends
- 2.2 Typhoid Vaccine Industry Drivers
- 2.3 Typhoid Vaccine Industry Opportunities and Challenges
- 2.4 Typhoid Vaccine Industry Restraints
- 3 Typhoid Vaccine Market by Company
- 3.1 Global Typhoid Vaccine Company Revenue Ranking in 2024
- 3.2 Global Typhoid Vaccine Revenue by Company (2020-2025)
- 3.3 Global Typhoid Vaccine Sales Volume by Company (2020-2025)
- 3.4 Global Typhoid Vaccine Average Price by Company (2020-2025)
- 3.5 Global Typhoid Vaccine Company Ranking (2023-2025)
- 3.6 Global Typhoid Vaccine Company Manufacturing Base and Headquarters
- 3.7 Global Typhoid Vaccine Company Product Type and Application
- 3.8 Global Typhoid Vaccine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Typhoid Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Typhoid Vaccine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Typhoid Vaccine Market by Type
- 4.1 Typhoid Vaccine Type Introduction
- 4.1.1 Oral Type Typhoid Vaccine
- 4.1.2 Injection Type Typhoid Vaccine
- 4.2 Global Typhoid Vaccine Sales Volume by Type
- 4.2.1 Global Typhoid Vaccine Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Typhoid Vaccine Sales Volume by Type (2020-2031)
- 4.2.3 Global Typhoid Vaccine Sales Volume Share by Type (2020-2031)
- 4.3 Global Typhoid Vaccine Sales Value by Type
- 4.3.1 Global Typhoid Vaccine Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Typhoid Vaccine Sales Value by Type (2020-2031)
- 4.3.3 Global Typhoid Vaccine Sales Value Share by Type (2020-2031)
- 5 Typhoid Vaccine Market by Application
- 5.1 Typhoid Vaccine Application Introduction
- 5.1.1 Pharmaceutical & Biotechnology Companies
- 5.1.2 Hospital
- 5.1.3 Research & Academic Laboratories
- 5.1.4 Others
- 5.2 Global Typhoid Vaccine Sales Volume by Application
- 5.2.1 Global Typhoid Vaccine Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Typhoid Vaccine Sales Volume by Application (2020-2031)
- 5.2.3 Global Typhoid Vaccine Sales Volume Share by Application (2020-2031)
- 5.3 Global Typhoid Vaccine Sales Value by Application
- 5.3.1 Global Typhoid Vaccine Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Typhoid Vaccine Sales Value by Application (2020-2031)
- 5.3.3 Global Typhoid Vaccine Sales Value Share by Application (2020-2031)
- 6 Typhoid Vaccine Regional Sales and Value Analysis
- 6.1 Global Typhoid Vaccine Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Typhoid Vaccine Sales by Region (2020-2031)
- 6.2.1 Global Typhoid Vaccine Sales by Region: 2020-2025
- 6.2.2 Global Typhoid Vaccine Sales by Region (2026-2031)
- 6.3 Global Typhoid Vaccine Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Typhoid Vaccine Sales Value by Region (2020-2031)
- 6.4.1 Global Typhoid Vaccine Sales Value by Region: 2020-2025
- 6.4.2 Global Typhoid Vaccine Sales Value by Region (2026-2031)
- 6.5 Global Typhoid Vaccine Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Typhoid Vaccine Sales Value (2020-2031)
- 6.6.2 North America Typhoid Vaccine Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Typhoid Vaccine Sales Value (2020-2031)
- 6.7.2 Europe Typhoid Vaccine Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Typhoid Vaccine Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Typhoid Vaccine Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Typhoid Vaccine Sales Value (2020-2031)
- 6.9.2 South America Typhoid Vaccine Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Typhoid Vaccine Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Typhoid Vaccine Sales Value Share by Country, 2024 VS 2031
- 7 Typhoid Vaccine Country-level Sales and Value Analysis
- 7.1 Global Typhoid Vaccine Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Typhoid Vaccine Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Typhoid Vaccine Sales by Country (2020-2031)
- 7.3.1 Global Typhoid Vaccine Sales by Country (2020-2025)
- 7.3.2 Global Typhoid Vaccine Sales by Country (2026-2031)
- 7.4 Global Typhoid Vaccine Sales Value by Country (2020-2031)
- 7.4.1 Global Typhoid Vaccine Sales Value by Country (2020-2025)
- 7.4.2 Global Typhoid Vaccine Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.9.2 France Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.16.2 China Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.19.2 India Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Typhoid Vaccine Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Typhoid Vaccine Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Typhoid Vaccine Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Actiza Pharmaceutical
- 8.1.1 Actiza Pharmaceutical Comapny Information
- 8.1.2 Actiza Pharmaceutical Business Overview
- 8.1.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
- 8.1.5 Actiza Pharmaceutical Recent Developments
- 8.2 Bharat Biotec
- 8.2.1 Bharat Biotec Comapny Information
- 8.2.2 Bharat Biotec Business Overview
- 8.2.3 Bharat Biotec Typhoid Vaccine Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio
- 8.2.5 Bharat Biotec Recent Developments
- 8.3 Merit Pharmaceuticals
- 8.3.1 Merit Pharmaceuticals Comapny Information
- 8.3.2 Merit Pharmaceuticals Business Overview
- 8.3.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
- 8.3.5 Merit Pharmaceuticals Recent Developments
- 8.4 PaxVax
- 8.4.1 PaxVax Comapny Information
- 8.4.2 PaxVax Business Overview
- 8.4.3 PaxVax Typhoid Vaccine Sales, Value and Gross Margin (2020-2025)
- 8.4.4 PaxVax Typhoid Vaccine Product Portfolio
- 8.4.5 PaxVax Recent Developments
- 8.5 GlaxoSmithKline
- 8.5.1 GlaxoSmithKline Comapny Information
- 8.5.2 GlaxoSmithKline Business Overview
- 8.5.3 GlaxoSmithKline Typhoid Vaccine Sales, Value and Gross Margin (2020-2025)
- 8.5.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
- 8.5.5 GlaxoSmithKline Recent Developments
- 8.6 Merck
- 8.6.1 Merck Comapny Information
- 8.6.2 Merck Business Overview
- 8.6.3 Merck Typhoid Vaccine Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Merck Typhoid Vaccine Product Portfolio
- 8.6.5 Merck Recent Developments
- 8.7 Sanofi
- 8.7.1 Sanofi Comapny Information
- 8.7.2 Sanofi Business Overview
- 8.7.3 Sanofi Typhoid Vaccine Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Sanofi Typhoid Vaccine Product Portfolio
- 8.7.5 Sanofi Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Typhoid Vaccine Value Chain Analysis
- 9.1.1 Typhoid Vaccine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Typhoid Vaccine Sales Mode & Process
- 9.2 Typhoid Vaccine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Typhoid Vaccine Distributors
- 9.2.3 Typhoid Vaccine Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.